Your browser doesn't support javascript.
loading
Show: 20 | 50 | 100
Results 1 - 2 de 2
Filter
Add more filters










Database
Language
Publication year range
1.
PLoS Genet ; 3(3): e41, 2007 Mar 16.
Article in English | MEDLINE | ID: mdl-17367211

ABSTRACT

Atypical hemolytic uremic syndrome (aHUS) is associated with defective complement regulation. Disease-associated mutations have been described in the genes encoding the complement regulators complement factor H, membrane cofactor protein, factor B, and factor I. In this study, we show in two independent cohorts of aHUS patients that deletion of two closely related genes, complement factor H-related 1 (CFHR1) and complement factor H-related 3 (CFHR3), increases the risk of aHUS. Amplification analysis and sequencing of genomic DNA of three affected individuals revealed a chromosomal deletion of approximately 84 kb in the RCA gene cluster, resulting in loss of the genes coding for CFHR1 and CFHR3, but leaving the genomic structure of factor H intact. The CFHR1 and CFHR3 genes are flanked by long homologous repeats with long interspersed nuclear elements (retrotransposons) and we suggest that nonallelic homologous recombination between these repeats results in the loss of the two genes. Impaired protection of erythrocytes from complement activation is observed in the serum of aHUS patients deficient in CFHR1 and CFHR3, thus suggesting a regulatory role for CFHR1 and CFHR3 in complement activation. The identification of CFHR1/CFHR3 deficiency in aHUS patients may lead to the design of new diagnostic approaches, such as enhanced testing for these genes.


Subject(s)
Blood Proteins/genetics , Complement C3b Inactivator Proteins/genetics , Complement Factor H/genetics , Gene Deletion , Genetic Predisposition to Disease , Hemolytic-Uremic Syndrome/genetics , Adolescent , Adult , Base Sequence , Blood Proteins/deficiency , Case-Control Studies , Chromosomes, Human/genetics , Complement C3b Inactivator Proteins/deficiency , Complement Factor H/deficiency , Exons/genetics , Gene Dosage , Gene Frequency , Gene Rearrangement , Humans , Molecular Sequence Data , Multigene Family
2.
PLoS Med ; 3(10): e431, 2006 Oct.
Article in English | MEDLINE | ID: mdl-17076561

ABSTRACT

BACKGROUND: Sequence analysis of the regulators of complement activation (RCA) cluster of genes at chromosome position 1q32 shows evidence of several large genomic duplications. These duplications have resulted in a high degree of sequence identity between the gene for factor H (CFH) and the genes for the five factor H-related proteins (CFHL1-5; aliases CFHR1-5). CFH mutations have been described in association with atypical haemolytic uraemic syndrome (aHUS). The majority of the mutations are missense changes that cluster in the C-terminal region and impair the ability of factor H to regulate surface-bound C3b. Some have arisen as a result of gene conversion between CFH and CFHL1. In this study we tested the hypothesis that nonallelic homologous recombination between low-copy repeats in the RCA cluster could result in the formation of a hybrid CFH/CFHL1 gene that predisposes to the development of aHUS. METHODS AND FINDINGS: In a family with many cases of aHUS that segregate with the RCA cluster we used cDNA analysis, gene sequencing, and Southern blotting to show that affected individuals carry a heterozygous CFH/CFHL1 hybrid gene in which exons 1-21 are derived from CFH and exons 22/23 from CFHL1. This hybrid encodes a protein product identical to a functionally significant CFH mutant (c.3572C>T, S1191L and c.3590T>C, V1197A) that has been previously described in association with aHUS. CONCLUSIONS: CFH mutation screening is recommended in all aHUS patients prior to renal transplantation because of the high risk of disease recurrence post-transplant in those known to have a CFH mutation. Because of our finding it will be necessary to implement additional screening strategies that will detect a hybrid CFH/CFHL1 gene.


Subject(s)
Hemolytic-Uremic Syndrome/genetics , Mutant Chimeric Proteins/genetics , Adult , Aged, 80 and over , Blotting, Southern , Complement C3b Inactivator Proteins/genetics , Complement Factor H/genetics , Complement System Proteins/genetics , DNA Breaks , DNA Mutational Analysis , Female , Gene Dosage , Genetic Predisposition to Disease , Humans , Male , Middle Aged , Nucleic Acid Amplification Techniques/methods , Polymerase Chain Reaction/methods , Sequence Analysis, DNA
SELECTION OF CITATIONS
SEARCH DETAIL
...